123 filings
Page 3 of 7
8-K
u4g8o4jalrxvxg
1 Apr 21
Departure of Directors or Certain Officers
8:42am
8-K
q6dh0g2s
5 Mar 21
Departure of Directors or Certain Officers
12:00am
8-K
zwf0tcj mans4m
25 Feb 21
Lantheus Reports Fourth Quarter and Full Year 2020 Financial Results
4:08pm
8-K
k3ss76w7
1 Feb 21
Other Events
7:00am
8-K
ze4tgj y4izj
9 Dec 20
Lantheus Holdings Announces Acceptance and Priority Review of New Drug Application for PyLTM (18F-DCFPyL), a PSMA-Targeted Prostate Cancer PET Imaging Agent
3:28pm
8-K
ada0y
3 Dec 20
Transaction Extends Relationship with Strategic Partner
7:06am
8-K
9e25aiu640w7hjqw
18 Nov 20
Lantheus Holdings, Inc. Announces FDA Approval of DEFINITY® Room Temperature
4:19pm
8-K
by4prarmiih61
5 Nov 20
Lantheus Holdings, Inc. Reports Third Quarter 2020 Financial Results
7:45am
8-K
c9t3fie0cpxq0oo6p8
5 Oct 20
Other Events
4:30pm
8-K
b062vdu3pflpna9h589
30 Sep 20
Other Events
8:15am
8-K
jvflxym9 1ohces6kx
30 Jul 20
Lantheus Holdings, Inc. Reports Second Quarter 2020 Financial Results
8:33am
8-K
tm5qhjhsucblxoffydyp
22 Jun 20
Entry into a Material Definitive Agreement
7:15am
8-K
yrw 2fzhfs
22 Jun 20
Lantheus Completes Merger with Progenics
7:12am
8-K
0l3w6af9v3naq l3d
16 Jun 20
Lantheus Stockholders Approve Share Issuance For Merger with Progenics
4:11pm
8-K
8rr2h5l
30 Apr 20
Lantheus Holdings, Inc. Reports First Quarter 2020 Financial Results
7:49am
8-K
2aynto ymx0ct0ke6
24 Apr 20
Submission of Matters to a Vote of Security Holders
4:31pm
8-K
cz8zo21f23 umqbaldi
14 Apr 20
Velan Capital Agrees to Support Merger of Lantheus and Progenics
9:02am
8-K
w8zcefcvk8 7gsl6h42s
10 Apr 20
Departure of Directors or Certain Officers
8:30am
8-K
pysh06jkv
9 Apr 20
Results of Operations and Financial Condition
8:30am
8-K
3q0 rgas9lcidz
2 Apr 20
Lantheus and Progenics Reschedule Their Respective Special Meetings of Stockholders for Proposed Merger
8:36am